These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36187410)

  • 1. The Ethical Relevance of "Alternatives" in Health Care Priority Setting - The Case of Preexposure Prophylaxis (PrEP) of HIV.
    Gustavsson E; Björk J
    Yale J Biol Med; 2022 Sep; 95(3):359-365. PubMed ID: 36187410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
    Venter F; Allais L; Richter M
    Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
    Marcus JL; Volk JE; Pinder J; Liu AY; Bacon O; Hare CB; Cohen SE
    Curr HIV/AIDS Rep; 2016 Apr; 13(2):116-24. PubMed ID: 26898645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice.
    Melody K; Roy CN; Kline C; Cottrell ML; Evans D; Shutt K; Pennings PS; Keele BF; Bility M; Kashuba ADM; Ambrose Z
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ; Bulled N
    Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
    Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
    MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
    Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Preexposure Prophylaxis: A Review.
    Riddell J; Amico KR; Mayer KH
    JAMA; 2018 Mar; 319(12):1261-1268. PubMed ID: 29584848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
    JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing HIV Infection in High-Risk Adolescents Using Preexposure Prophylaxis (PrEP).
    Blackwell CW
    J Assoc Nurses AIDS Care; 2018; 29(5):770-774. PubMed ID: 30146018
    [No Abstract]   [Full Text] [Related]  

  • 15. Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach.
    Myers JE; Edelstein ZR; Daskalakis DC; Gandhi AD; Misra K; Rivera AV; Salcuni PM; Scanlin K; Udeagu CC; Braunstein SL
    Am J Public Health; 2018 Nov; 108(S4):S251-S257. PubMed ID: 30383427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis.
    Luong Nguyen LB; Freedberg KA; Wanjala S; Maman D; Szumilin E; Mendiharat P; Yazdanpanah Y
    J Infect Dis; 2022 Mar; 225(6):1032-1039. PubMed ID: 33106850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
    Herron PD
    LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.
    Irie WC; Calabrese SK; Patel RR; Mayer KH; Geng EH; Marcus JL
    AIDS Behav; 2022 Jul; 26(7):2212-2223. PubMed ID: 34985607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".
    Hoffman S; Guidry JA; Collier KL; Mantell JE; Boccher-Lattimore D; Kaighobadi F; Sandfort TG
    J Int Assoc Provid AIDS Care; 2016; 15(1):59-65. PubMed ID: 26293904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency Department-Based Human Immunodeficiency Virus Preexposure Prophylaxis Referral Program-Using Emergency Departments as a Portal for Preexposure Prophylaxis Services.
    Zhao Z; Jones J; Arrington-Sanders R; Gladfelter G; McDonald S; Reed C; Myer D; Schlenker N; Fulton G; Jones T; Saheed M; Rothman R; Hsieh YH
    Sex Transm Dis; 2021 Aug; 48(8):e102-e104. PubMed ID: 33433172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.